EMAIL DETAILS
SUBJECT:
RE: next steps
PRI: NORMAL
FROM:
M
marci.rodriguez@nantworks.com
DATE:
2015-03-10 04:09:10
MSG_ID:
<DECEB0AD94C41543869664535A590E4DC9856E7E@C01RESV005.RES.corp>
RECIPIENTS:
TO:
H
Howard Krein
<howard@startuphealth.com>
W
Yung,W K Alfred
<wyung@mdanderson.org>
CC:
2
Beau Biden
<261penn@gmail.com>
C
Cassian Yee
<cassianyee@me.com>
G
Mills,Gordon B
<gmills@mdanderson.org>
H
Hallie Biden
<halliebiden@gmail.com>
K
Kim Nicholson
<kim.nicholson@swedish.org>
K
Shaw,Kenna R
<krshaw@mdanderson.org>
L
Chin,Lynda
<lchin@mdanderson.org>
M
Mark Hyman
<mark@ultrawellnesscenter.com>
P
Phil Yang
<phil.yang@nantworks.com>
P
Hwu,Patrick
<phwu@mdanderson.org>
P
Patrick Soon-Shiong
<pss@nantworks.com>
R
DePinho,Ronald A
<rdepinho@mdanderson.org>
R
Hunter Biden
<rhb@rspdc.com>
S
Shahrooz Rabizadeh
<shahrooz@nantworks.com>
CONTENT:
TEXT: YES |
HTML: YES
PROCESSED
Dr. Krein, Yes that works for Dr. Soon-Shiong. Please feel free to send the dial –in# for the 4:00pm pst call tomorrow. Thank you, Marci Rodriguez Executive Assistant to Patrick Soon-Shiong, M.D. NantWorks LLC 9920 Jefferson Blvd. Culver City, CA 90232 Phone# 310-853-7801 Email: marci@nantworks.com<mailto:marci@nantworks.com> From: Howard Krein [mailto:howard@startuphealth.com] Sent: Monday, March 09, 2015 6:33 PM To: Yung,W K Alfred Cc: Patrick Soon-Shiong; Mark Hyman; Hunter Biden; Hallie Biden; Beau Biden; Kim Nicholson; Phil Yang; Marci Rodriguez; Shahrooz Rabizadeh; Mills,Gordon B; Hwu,Patrick; Chin,Lynda; Cassian Yee; Shaw,Kenna R; DePinho,Ronald A Subject: Re: next steps Al and Patrick, As long as tomorrow at 4pm PST (7am Hong Kong) works I will send call in number for the three of us to connect and further discuss options/plans as well serve as an introduction. thanks again and looking forward to speaking with both of you tomorrow evening. Warmly, Howard On Mon, Mar 9, 2015 at 8:16 PM, Yung,W K Alfred <wyung@mdanderson.org<mailto:wyung@mdanderson.org>> wrote: We have done deep molecular analysis on Beau's original tumor with our T200 panel and WGS. The profile is quite bland, not too many mutations is found, major GBM associated genes like EGFR, PTEN, PIK3CA, PDGFRA, HER2 are negative, only 2 positive hits: p53 and PTPN11. IHC showed increase pAKT, PDGFRA, pMAPK. Patrick's team have identified 10 over-expressed peptides for the preparation of an immuned-T-cell vaccine which we planned to use with the anti-PD1. I certainly welcome any help we can get. We have planned to do another round of deep molecule analysis of the new tumor after it is removed next week. Al W. K. Alfred Yung, M.D. Chair,Department of Neuro-Oncology UT M.D. Anderson Cancer Center 1515 Holcombe Blvd. Houston, TX 77030 713-794-1285<tel:713-794-1285> From: Patrick Soon-Shiong <pss@nantworks.com<mailto:pss@nantworks.com>> Date: Monday, March 9, 2015 9:36 AM To: Howard Krein <howard@startuphealth.com<mailto:howard@startuphealth.com>>, Mark Hyman <Mark@ultrawellnesscenter.com<mailto:Mark@ultrawellnesscenter.com>> Cc: Hunter Biden <rhb@rspdc.com<mailto:rhb@rspdc.com>>, Hallie Beiden <halliebiden@gmail.com<mailto:halliebiden@gmail.com>>, Beau Biden <261penn@gmail.com<mailto:261penn@gmail.com>>, Alfred Yung <wyung@mdanderson.org<mailto:wyung@mdanderson.org>>, Kim Nicholson <Kim.Nicholson@swedish.org<mailto:Kim.Nicholson@swedish.org>>, Phil Yang <phil.yang@nantworks.com<mailto:phil.yang@nantworks.com>>, Marci Rodriguez <Marci.Rodriguez@nantworks.com<mailto:Marci.Rodriguez@nantworks.com>>, Shahrooz Rabizadeh <Shahrooz@nantworks.com<mailto:Shahrooz@nantworks.com>> Subject: Re: next steps Dear Howard and Mark Happy to help in anyway we can. As a first step we should retieve the tissue (both the paraffin block and the fresh frozen) from the surgery performed a year ago. We could begin the panomic sequencing on that sample now and before the next surgery. We will look for eGfr and Her+ markers as potential targets for the NK92 treatment. Kim will reach out to you today. Also will coordinate a call for Tuesday with our team to review all images to date Keep well Patrick Sent from my BlackB erry 10 smartphone on the Verizon Wireless 4G LTE network. From: Howard Krein Sent: Monday, March 9, 2015 5:36 AM To: Mark Hyman Cc: Hunter Biden; Hallie Biden; Beau Biden; Patrick Soon-Shiong; Al Yung MD Subject: Re: next steps Mark, Thank you once again for arranging this. I had a conversation with Al last night and he is on board with everything. He is in Hong Kong till Thursday but will be available to do a call with Patrick Tuesday at 4 PM PST if that works. He also realizes the time constraints we are under and doesn't want to miss any potential opportunities. I can arrange a call in number if that works for Patrick. Warmly, Howard Howard D. Krein MD, PhD Assistant Professor Div. of Facial Plastics and Reconstructive Surgery Dept. of Otolaryngology/ Head and Surgery Thomas Jefferson University 215-955-6760<tel:215-955-6760> StartUp Health Chief Medical Officer Howard@startuphealth.com<mailto:Howard@startuphealth.com> On Mar 9, 2015, at 1:41 AM, Mark Hyman <Mark@ultrawellnesscenter.com<mailto:Mark@ultrawellnesscenter.com>> wrote: Dear All, I am writing to connect everyone so Dr. Patrick can start the process of gaining access to records and set up integrated team meeting as the next step. Thanks for all your time today and allowing us to be part of your care team. I have also copied Dr. Yung so that he and Dr. Patrick can connect directly to expedite care coordination. Be well, Mark ------------------ Mark Hyman, MD Director, Cleveland Clinic Center for Functional Medicine Founder and Medical Director The UltraWellness Center Chairman, Institute for Functional Medicine 55 Pittsfield Road, Suite 9 Lenox Commons Lenox, MA 01240 (413) 637-9991<tel:%28413%29%20637-9991> mark@drhyman.com<mailto:mark@drhyman.com> www.drhyman.com<http://www.drhyman.com> Follow me: Facebook<http://www.facebook.com/drmarkhyman> Twitter<https://twitter.com/#!/markhymanmd> Linked In<http://www.linkedin.com/in/drhyman> Confidentiality Notice: This e-mail message and any attachments from The UltraWellness Center are confidential and for the sole use of the intended recipient. This communication may contain Protected Health Information (“PHI”). PHI is confidential information that may only be used or disclosed in accordance with applicable law. There are penalties under the law for the improper use or further disclosure of PHI. If you are not the intended recipient of this e-mail or the employee or agent responsible for delivering the communication to the intended recipient, then you may not read, copy, distribute or otherwise use or disclose the information contained in this message. If you received this message in error, please notify us by return email and delete this email from your system. CONFIDENTIALITY NOTICE This e-mail message and any attachments are only for the use of the intended recipient and may contain information that is privileged, confidential or exempt from disclosure under applicable law. If you are not the intended recipient, any disclosure, distribution or other use of this e-mail message or attachments is prohibited. If you have received this e-mail message in error, please delete and notify the sender immediately. Thank you. -- Howard D. Krein MD, PhD Assistant Professor Div. of Facial Plastics and Reconstructive Surgery Dept. of Otolaryngology/ Head and Surgery Thomas Jefferson University 215-955-6760 Chief Medical Officer -StartUp Health startuphealth.com<http://startuphealth.com>
METADATA:
THREAD:
TOPIC:
next steps
INDEX:
AQHQWmWlpopzdaux40KJ5FGcMFJm3p0UOC6QgAEXSQCAABVdAP//tg1w
REFERENCES:
REPLY_TO:
<CAC7OM1fnUafGKV_R5DZnAHMF9rFdg+o0+Xmj34L7W1DZ9yVFAQ@mail.gmail.com>
REFS:
<D1239D5B.1D4DD%wyung@mdanderson.org>
<D122AA63.11CFCD%mark@ultrawellnesscenter.com>
<20150309143653.17731659.44855.7011@nantworks.com>
<957C7825-6DA2-4666-847D-21938AD60CFE@startuphealth.com>
<CAC7OM1fnUafGKV_R5DZnAHMF9rFdg+o0+Xmj34L7W1DZ9yVFAQ@mail.gmail.com>